These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 24975667)
1. Chemistry and biology of glycopeptides with antibiotic activity. Tan H; Guo H; Wang S; Kong Q; Li W; Zeng W Protein Pept Lett; 2014; 21(10):1031-47. PubMed ID: 24975667 [TBL] [Abstract][Full Text] [Related]
2. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030 [TBL] [Abstract][Full Text] [Related]
4. Solid- and solution-phase synthesis of vancomycin and vancomycin analogues with activity against vancomycin-resistant bacteria. Nicolaou KC; Cho SY; Hughes R; Winssinger N; Smethurst C; Labischinski H; Endermann R Chemistry; 2001 Sep; 7(17):3798-823. PubMed ID: 11575782 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles. Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428 [TBL] [Abstract][Full Text] [Related]
6. Glycopeptide antibiotics: from conventional molecules to new derivatives. Van Bambeke F; Van Laethem Y; Courvalin P; Tulkens PM Drugs; 2004; 64(9):913-36. PubMed ID: 15101783 [TBL] [Abstract][Full Text] [Related]
7. Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B. Yoshida O; Yasukata T; Sumino Y; Munekage T; Narukawa Y; Nishitani Y Bioorg Med Chem Lett; 2002 Nov; 12(21):3027-31. PubMed ID: 12372494 [TBL] [Abstract][Full Text] [Related]
8. Redesign of glycopeptide antibiotics: back to the future. James RC; Pierce JG; Okano A; Xie J; Boger DL ACS Chem Biol; 2012 May; 7(5):797-804. PubMed ID: 22330049 [TBL] [Abstract][Full Text] [Related]
9. Glycopeptide antibiotics and their novel semi-synthetic derivatives. Jeya M; Moon HJ; Lee KM; Kim IW; Lee JK Curr Pharm Biotechnol; 2011 Aug; 12(8):1194-204. PubMed ID: 21470154 [TBL] [Abstract][Full Text] [Related]
10. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Barna JC; Williams DH Annu Rev Microbiol; 1984; 38():339-57. PubMed ID: 6388496 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin. Printsevskaya SS; Solovieva SE; Olsufyeva EN; Mirchink EP; Isakova EB; De Clercq E; Balzarini J; Preobrazhenskaya MN J Med Chem; 2005 Jun; 48(11):3885-90. PubMed ID: 15916441 [TBL] [Abstract][Full Text] [Related]
12. Developments in Glycopeptide Antibiotics. Blaskovich MAT; Hansford KA; Butler MS; Jia Z; Mark AE; Cooper MA ACS Infect Dis; 2018 May; 4(5):715-735. PubMed ID: 29363950 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of oritavancin and related glycopeptide antibiotics. Allen NE; Nicas TI FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393 [TBL] [Abstract][Full Text] [Related]